Oncimmune Holdings PLC – Final Results

31 October 2019 - Oncimmune Holdings plc (AIM:ONC.L), the leading global immunodiagnostics group, today announces its preliminary unaudited full year results for the year ended 31 May 2019. The audited...

Read More

Oncimmune Holdings PLC – Half Year Results

Oncimmune Holdings plc (AIM: ONC.L), a leader in the development, manufacture and commercialisation of personalised immunodiagnostics for the screening, detection and care of cancer, today announces its half year results for...

Read More

Oncimmune Holdings plc – Business Update

Oncimmune Holdings plc (AIM: ONC.L), a leading early cancer detection company developing and commercialising its proprietary EarlyCDT® liquid biopsy platform technology, today provides an update on the business ahead of its...

Read More